BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22370992)

  • 1. Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: a double-blind, placebo-controlled, randomized trial.
    Yui K; Koshiba M; Nakamura S; Kobayashi Y
    J Clin Psychopharmacol; 2012 Apr; 32(2):200-6. PubMed ID: 22370992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic effects of larger doses of arachidonic acid added to DHA on social impairment and its relation to alterations of polyunsaturated fatty acids in individuals with autism spectrum disorders].
    Yui K; Koshiba M; Nakamura S; Onishi M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Jun; 31(3):117-24. PubMed ID: 21800702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fish oil supplementation on quality of life in a general population of older Dutch subjects: a randomized, double-blind, placebo-controlled trial.
    van de Rest O; Geleijnse JM; Kok FJ; van Staveren WA; Olderikkert MG; Beekman AT; de Groot LC
    J Am Geriatr Soc; 2009 Aug; 57(8):1481-6. PubMed ID: 19549020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study.
    Amminger GP; Berger GE; Schäfer MR; Klier C; Friedrich MH; Feucht M
    Biol Psychiatry; 2007 Feb; 61(4):551-3. PubMed ID: 16920077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-chain polyunsaturated fat supplementation in children with low docosahexaenoic acid intakes alters immune phenotypes compared with placebo.
    Mazurak VC; Lien V; Field CJ; Goruk SD; Pramuk K; Clandinin MT
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):570-9. PubMed ID: 18493214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential fatty acid supplementation of DHA and ARA and effects on neurodevelopment across animal species: a review of the literature.
    Davis-Bruno K; Tassinari MS
    Birth Defects Res B Dev Reprod Toxicol; 2011 Jun; 92(3):240-50. PubMed ID: 21678548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
    Hamazaki K; Itomura M; Huan M; Nishizawa H; Sawazaki S; Tanouchi M; Watanabe S; Hamazaki T; Terasawa K; Yazawa K
    Nutrition; 2005 Jun; 21(6):705-10. PubMed ID: 15925295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile and enzymatic anti-oxidant capacity of seminal plasma in infertile men with idiopathic oligoasthenoteratospermia: a double-blind, placebo-controlled, randomised study.
    Safarinejad MR
    Andrologia; 2011 Feb; 43(1):38-47. PubMed ID: 21219381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
    Voigt RG; Llorente AM; Jensen CL; Fraley JK; Berretta MC; Heird WC
    J Pediatr; 2001 Aug; 139(2):189-96. PubMed ID: 11487742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials.
    Hoffman DR; Boettcher JA; Diersen-Schade DA
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):151-8. PubMed ID: 19505812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of arachidonic acids on social behavior in patients with autism spectrum disorders].
    Yui K; Murphy D; Hamakawa H
    Seishin Shinkeigaku Zasshi; 2009; 111(11):1387-96. PubMed ID: 20217968
    [No Abstract]   [Full Text] [Related]  

  • 14. Docosahexaenoic acid in red blood cells of term infants receiving two levels of long-chain polyunsaturated fatty acids.
    Hoffman DR; Wheaton DK; James KJ; Tuazon M; Diersen-Schade DA; Harris CL; Stolz S; Berseth CL
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):287-92. PubMed ID: 16540798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of arachidonate-enriched triacylglycerol supplementation on serum fatty acids and platelet aggregation in healthy male subjects with a fish diet.
    Kusumoto A; Ishikura Y; Kawashima H; Kiso Y; Takai S; Miyazaki M
    Br J Nutr; 2007 Sep; 98(3):626-35. PubMed ID: 17445350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.
    Lloyd-Still JD; Powers CA; Hoffman DR; Boyd-Trull K; Lester LA; Benisek DC; Arterburn LM
    Nutrition; 2006 Jan; 22(1):36-46. PubMed ID: 16226012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial.
    Koch C; Dölle S; Metzger M; Rasche C; Jungclas H; Rühl R; Renz H; Worm M
    Br J Dermatol; 2008 Apr; 158(4):786-92. PubMed ID: 18241260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population.
    Stough C; Downey L; Silber B; Lloyd J; Kure C; Wesnes K; Camfield D
    Neurobiol Aging; 2012 Apr; 33(4):824.e1-3. PubMed ID: 21531481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.
    Sandler AD; Sutton KA; DeWeese J; Girardi MA; Sheppard V; Bodfish JW
    N Engl J Med; 1999 Dec; 341(24):1801-6. PubMed ID: 10588965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of arachidonic, eicosapentaenoic and docosahexaenoic acids on the oxidative status of C6 glioma cells.
    Leonardi F; Attorri L; Di Benedetto R; Di Biase A; Sanchez M; Nardini M; Salvati S
    Free Radic Res; 2005 Aug; 39(8):865-74. PubMed ID: 16036367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.